| 1 |
Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study.
|
|
|
|
In: HIV medicine, vol. 23, no. 4, pp. 441-447 (2022)
|
|
BASE
|
|
Show details
|
|
|
| 2 |
A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study.
|
|
|
|
In: Journal of medical Internet research, vol 23, iss 3 (2021)
|
|
BASE
|
|
Show details
|
|
|
| 3 |
New Directions in Treatments Targeting Stroke Recovery.
|
|
|
|
In: Stroke, vol 49, iss 12 (2018)
|
|
BASE
|
|
Show details
|
|
|
| 4 |
Cognitive Working Memory Training (CWMT) in adolescents suffering from Attention-Deficit/Hyperactivity Disorder (ADHD): A controlled trial taking into account concomitant medication effects.
|
|
|
|
In: Psychiatry research, vol. 269, pp. 79-85 (2018)
|
|
BASE
|
|
Show details
|
|
|
| 5 |
Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trial.
|
|
|
|
BASE
|
|
Show details
|
|
|
| 6 |
Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trial.
|
|
|
|
BASE
|
|
Show details
|
|
|
| 7 |
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial
|
|
|
|
In: PMC (2013)
|
|
BASE
|
|
Show details
|
|
|
| 8 |
Innovative solutions to novel drug development in mental health.
|
|
|
|
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2013)
|
|
BASE
|
|
Show details
|
|
|
| 9 |
Innovative solutions to novel drug development in mental health.
|
|
|
|
In: Neurosci Biobehav Rev , 37 (10 Pt 1) pp. 2438-2444. (2013) (2013)
|
|
BASE
|
|
Show details
|
|
|
| 10 |
Association between ambulatory 24-hour blood pressure levels and brain volume reduction: a cross-sectional elderly population-based study
|
|
|
|
In: ISSN: 1524-4563 ; Hypertension (Dallas, Tex. : 1979) ; https://hal.univ-angers.fr/hal-03355591 ; Hypertension (Dallas, Tex. : 1979), 2012, 60 (5), pp.1324-31. ⟨10.1161/hypertensionaha.112.193409⟩ (2012)
|
|
Abstract:
International audience ; Previous literature has shown mixed results regarding the association between blood pressure levels and brain volume reduction. The objectives of this study were to determine whether high blood pressure levels were associated with focal brain volume reduction and whether high blood pressure-related focal brain volume reduction was associated with a decline in executive function performance. On the basis of a cross-sectional design, 24-hour ambulatory blood pressure measurements, as well as brain morphology from 3-dimensional magnetic resonance images, were assessed among 183 participants (mean, 65 +/- 0.6 years; 62.4% women). Average levels of systolic and diastolic blood pressures, as well as dip, pulse pressure, and mean arterial blood pressure, were used as outcomes. Cortical gray and white matter volumes were determined by automatic calculation using Statistical Parametric Mapping segmentation. Folstein's Mini-Mental State Examination, digit span, part B of Trail Making, and Stroop tests were used to assess executive function performance. Sex, use of antihypertensive drugs, duration of hypertension, leukoaraiosis, body mass index, education level, and total brain matter volume were used as potential confounders. A significant blood pressure-related decrease in gray matter volume of the left supplementary motor areas (Brodmann area 6) and of the left superior and middle frontal gyrus (Brodmann area 8) was shown. No significant decrease was found with white matter volume. Blood pressure-related decreases in gray matter volume were significantly associated with a decline in executive function performance. The association of high blood pressure with brain volume reduction may in part explain blood pressure-related cognitive decline leading to dementia.
|
|
Keyword:
[SHS]Humanities and Social Sciences; Aged; Ambulatory/ methods; Antihypertensive Agents/therapeutic use; Blood Pressure Monitoring; Blood Pressure/drug effects/ physiology; Brain Mapping; Brain/ pathology/physiopathology; Cognition/physiology; Cross-Sectional Studies; Female; Humans; Hypertension/drug therapy/physiopathology; Linear Models; Magnetic Resonance Imaging/ methods; Male; Middle Aged; Multivariate Analysis; Population Surveillance/methods; Psychomotor Performance/physiology; Time Factors
|
|
URL: https://doi.org/10.1161/hypertensionaha.112.193409
https://hal.univ-angers.fr/hal-03355591
|
|
BASE
|
|
Hide details
|
|
|
| 11 |
Basal insulin and cardiovascular and other outcomes in dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
|
|
BASE
|
|
Show details
|
|
|
| 12 |
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
|
|
BASE
|
|
Show details
|
|
|
| 13 |
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
|
|
BASE
|
|
Show details
|
|
|
| 14 |
Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo
|
|
|
|
In: ISSN: 1545-9683 ; Neurorehabilitation and Neural Repair, Vol. 25, No 1 (2011) pp. 43-47 (2011)
|
|
BASE
|
|
Show details
|
|
|
| 15 |
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.
|
|
|
|
In: Journal of Bone and Mineral Research, vol. 26, no. 5, pp. 984-992 (2011)
|
|
BASE
|
|
Show details
|
|
|
| 16 |
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
|
|
|
|
In: Osteoporosis International, vol. 21, no. 7, pp. 1277-1285 (2010)
|
|
BASE
|
|
Show details
|
|
|
| 17 |
Pharmacotherapy and children with autism spectrum disorder: a tutorial for speech-language pathologists
|
|
|
|
In: NLM (2010)
|
|
BASE
|
|
Show details
|
|
|
| 18 |
Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study.
|
|
Chu VH, Miro JM, Hoen B, Cabell CH, Pappas PA, Jones P, Stryjewski ME, Anguera I, Braun S, Muñoz P, Commerford P, Tornos P, Francis J, Oyonarte M, Selton-Suty C, Morris AJ, Habib G, Almirante B, Sexton DJ, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis-Prospective Cohort Study Group. Collaborators: Gordon D, Devi U, Spelman D, van der Meer JT, Kauffman C, Bradley S, Armstrong W, Giannitsioti E, Giamarellou H, Lerakis S, del Rio A, Moreno A, Mestres CA, Pare C, Garcia de la Maria C, Claramonte X, Armero Y, De Lazzario E, Marco F, Gatell JM, Miro JM, Almela M, Azqueta M, Jiménez-Expósito MJ, de Benito N, Ramirez J, Perez N, Almirante B, Fernandez-Hidalgo N, Rodriguez de Vera P, Tornos P, Falcó V, Sidani N, Kanj-Sharara S, Kanafani Z, Raglio A, Goglio A, Gnecchi F, Suter F, Valsecchi G, Rizzi M, Ravasio V, Hoen B, Chirouze C, Giannitsioti E, Leroy J, Plesiat P, Bernard Y, Casey A, Lambert P, Watkin R, Elliott T, Patel M, Dismukes W, Pan A, Caros G, Tribouilloy AB, Goissen T, Delahaye A, Delahaye F, Vandenesch F, Vizzotti C, Nacinovich FM, Marin M, Trivi M, Lombardero M, Cortes C, Casabe JH, Altclas J, Kogan S, Clara L, Sanchez M, Commerford A, Hansa C, Deetlefs E, Ntsekhe M, Commerford P, Wray D, Steed LL, Church P, Cantey R, Morris A, Holland D, Murdoch D, Read K, Raymond N, Lang S, Chambers S, Kotsanas D, Korman TM, Peterson G, Purcell J, Southern PM Jr, Shah M, Bedimo R, Reddy A, Levine D, Dhar G, Hanlon-Feeney A, Hannan M, Kelly S, Wang A, Cabell CH, Woods CW, Sexton DJ, Benjamin D Jr, Corey GR, McDonald JR, Federspiel J, Engemann JJ, Reller LB, Drew L, Caram LB, Stryjewski M, Morpeth S, Lalani T, Fowler V Jr, Chu V, Mazaheri B, Neuerburg C, Naber C, Athan E, Henry M, Harris O, Alestig E, Olaison L, Wikstrom L, Snygg-Martin U, Francis J, Venugopal K, Nair L, Thomas V, Chaiworramukkun J, Pachirat O, Chetchotisakd P, Suwanich T, Kamarulzaman A, Tamin SS, Premru MM, Logar M, Lejko-Zupanc T, Orezzi C, Klein J, Bouza E, Moreno M, Rodríguez-Créixems M, Marín M, Fernández M, Muñoz P, Fernández R, Ramallo V, Raoult D, Thuny F, Habib G, Casalta JP, Fournier PE, Chipigina N, Kirill O, Vinogradova T, Kulichenko VP, Butkevich OM, Lion C, Selton-Suty C, Alla F, Coyard H, Doco-Lecompte T, Iarussi D, Durante-Mangoni E, Ragone E, Dialetto G, Tripodi MF, Utili R, Casillo R, Kumar AS, Sharma G, Dickerman SA, Street A, Eisen DP, Grigg L, Abrutyn E, Michelet C, Tattevin P, Donnio PY, Fortes CQ, Edathodu J, Al-Hegelan M, Font B, Anguera I, Guma JR, Cereceda M, Oyonarte MJ, Mella RM, Garcia P, Jones SB, Ramos AI, Paiva MG, Tranchesi RA, Woon LL, Lum LN, Tan RS, Rees D, Kornecny P, Lawrence R, Dever R, Post J, Jones P, Ryan S, Harkness J, Feneley M, Rubinstein E, Strahilewitz J, Ionac A, Mornos C, Dragulescu S, Forno D, Cecchi E, De Rosa F, Imazio M, Trinchero R, Wiesbauer F, Gattringer R, Rubinstein E, Deans G, Andrasevic AT, Barsic B, Klinar I, Vincelj J, Bukovski S, Krajinovic V.. - 2009
|
|
BASE
|
|
Show details
|
|
|
| 19 |
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
|
|
|
|
In: New England Journal of Medicine, vol. 361, no. 8, pp. 756-765 (2009)
|
|
BASE
|
|
Show details
|
|
|
| 20 |
Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
|
|
|
|
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2008)
|
|
BASE
|
|
Show details
|
|
|
|
|
